Q32 Bio shares are trading higher after the company reported better-than-expected Q4 adjusted EPS results.
Homology Medicines, Inc. +2.64%
Homology Medicines, Inc. QTTB | 5.05 | +2.64% |
Q32 Bio shares are trading higher after the company reported better-than-expected Q4 adjusted EPS results.
